Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
New SNAP Work Rules Risk Food Access for Millions
Public Policy New SNAP Work Rules Risk Food Access for Millions

In the heart of Austin, Texas, Alejandro Santillan-Garcia, a 20-year-old who aged out of foster care, sits in a cramped apartment, his refrigerator nearly empty. Each day, he scours job listings, sends out applications, and walks miles to interviews without reliable transportation, yet steady work

Will Telehealth Waivers Survive the Post-Pandemic Era?
Public Policy Will Telehealth Waivers Survive the Post-Pandemic Era?

Imagine a world where a rural patient, miles from the nearest clinic, receives life-saving mental health support through a simple phone call, or a busy parent consults a doctor via video without leaving home. This isn’t a distant dream but a reality forged during the crucible of a global health c

Who Qualifies as 'Medically Frail' in Medicaid Rules?
Public Policy Who Qualifies as 'Medically Frail' in Medicaid Rules?

Imagine being one of the millions of Americans who depend on Medicaid for lifesaving healthcare, only to learn that new rules could strip that coverage away unless you prove you’re working—or prove you’re too sick to work. Set to take effect in 2027, these federal Medicaid work requirements mandate

Rosen Law Firm Alerts MOH Investors to Class Action Deadline
Public Policy Rosen Law Firm Alerts MOH Investors to Class Action Deadline

A swift sequence of disclosures, market reactions, and legal milestones shaped a clear chronology for investors who bought Molina Healthcare, Inc. (NYSE: MOH) securities in early to mid-2025 and then saw risk details emerge that allegedly cut against prior guidance and cost trend assumptions,

Will HSAs Replace ACA Credits in Health Care Reform?
Public Policy Will HSAs Replace ACA Credits in Health Care Reform?

As we dive into the complex world of health care reform, I’m thrilled to speak with Faisal Zain, a renowned expert in health policy with a deep understanding of the Affordable Care Act (ACA) and innovative approaches to insurance markets. With the potential expiration of enhanced premium tax c

Trump's Deportation Policies Disrupt Immigrant Healthcare
Public Policy Trump's Deportation Policies Disrupt Immigrant Healthcare

The landscape of immigrant life in the United States has undergone a seismic shift under President Donald Trump's second administration, with deportation policies casting a long shadow over communities nationwide. Reports of heightened fear and anxiety among immigrants—whether undocumented, h

FDA Approves Bayer's Hyrnuo to Rival Hernexeos in NSCLC
Public Policy FDA Approves Bayer's Hyrnuo to Rival Hernexeos in NSCLC

Introduction to a Shifting Landscape in Lung Cancer Treatment In the realm of oncology, non-small cell lung cancer (NSCLC) remains a formidable challenge, accounting for a significant portion of cancer diagnoses worldwide, and within this broad category, a small but critical subset—HER2-mutant N

Secure AI in Healthcare: Balancing Privacy and Innovation
Public Policy Secure AI in Healthcare: Balancing Privacy and Innovation

In an era where artificial intelligence is revolutionizing healthcare with unprecedented speed, a staggering concern looms large: nearly 80% of healthcare data breaches involve sensitive patient information being exposed due to inadequate privacy measures. This alarming statistic underscores the

Modular Medical Submits Pivot Insulin Pump for FDA Clearance
Public Policy Modular Medical Submits Pivot Insulin Pump for FDA Clearance

Introduction to Diabetes Care Innovations In a world where over 38 million Americans live with diabetes, the quest for effective, user-friendly management tools has never been more critical, especially as the burden of daily insulin injections and complex treatment regimens often deters patients

FDA's Biosimilar Boost Faces Patent Office Roadblocks
Public Policy FDA's Biosimilar Boost Faces Patent Office Roadblocks

Today, we’re diving into the complex world of biosimilar drugs and regulatory challenges with Faisal Zain, a renowned healthcare expert specializing in medical technology. With his extensive background in the manufacturing of medical devices for diagnostics and treatment, Faisal brings a unique p

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later